The American Petroleum Institute (API) said Tuesday it now opposes legislation that would allow year-round sales of E15 gasoline, citing dramatic changes in market conditions that have led to a ...

Merck will invest $3 billion in a new pharmaceutical manufacturing facility in Virginia, creating 500 jobs and expanding U.S.

Merith Basey, executive director of Patients for Affordable Drugs Now, said in response to the updated CBO analysis that “the ORPHAN Cures Act is a wildly expensive handout to Big Pharma that will ...

Shuttle Pharmaceuticals Holdings, Inc. ( ($SHPH) ) has issued an announcement. On October 20, 2025, Shuttle Pharmaceuticals Holdings, Inc. entered ...

Lobbying by the health industry’s largest players so far this year jumped 13 percent over the same time in 2024.

A provision of the summer’s One Big Beautiful Bill Act bumping a slew of orphan drugs from Medicare price negotiation is ...

For nearly 85 years, the Merck & Co. Campus in Elkton has been committed to manufacturing pharmaceutical tools and now are ...

The company plans to invest a total of $200 million in the region for its operations.

A rebound in pharmaceutical-research investment would be a boost to Danaher, which provides technologies and tools for drug development. The Washington, D.C., company reiterated its full-year profit ...

The life sciences and diagnostics company posted sales of $6.05 billion and stands to benefit from an increase in ...

It's the latest in a string of announcements by pharmaceutical manufacturers to build or expand operations in Virginia.